Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inxadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

M. Humbert, R. Beasley, Jonathan Geoffrey Ayres, R. Slavin, J. Herbert

    Research output: Contribution to journal › Article › peer-review

    1042 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inxadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE'. Together they form a unique fingerprint.

    Medicine & Life Sciences